Vireo Growth (VREOF) Capital Expenditures (2020 - 2026)

Vireo Growth's (VREOF) quarterly Capital Expenditures came in at $10.8 million in Q1 2026, up 881.82% year-on-year from $1.1 million in Q1 2025, and up 9.51% quarter-over-quarter from $9.9 million in Q4 2025.

Vireo Growth (VREOF) Capital Expenditures (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Capital Expenditures across 7 years of filings, most recently posting $10.8 million for Q1 2026.

  • Capital Expenditures for Q1 2026 came in at $10.8 million, up 881.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.0 million (up 219.65% YoY), and the FY2025 annual result was $28.3 million, up 142.19% from the prior year.
  • Capital Expenditures came in at $10.8 million for Q1 2026 at Vireo Growth, up from $9.9 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $13.7 million in Q3 2025 to a low of $152079.0 in Q3 2023.
  • The 5-year median for Capital Expenditures is $2.3 million (2023), against an average of $3.6 million.
  • Across the five-year window, Capital Expenditures plunged 90.9% in 2023 and soared 3112.91% in 2024, its largest moves.
  • Vireo Growth's Capital Expenditures stood at $623076.0 in 2022, then surged by 274.33% to $2.3 million in 2023, then climbed by 16.62% to $2.7 million in 2024, then soared by 262.57% to $9.9 million in 2025, then grew by 9.51% to $10.8 million in 2026.
  • The last three Capital Expenditures figures came in at $10.8 million (Q1 2026), $9.9 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 168.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.09 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 8.83 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.04 Mn
10 Vireo Growth - - 59.30 Mn 10.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.80 Mn
Mar 31, 2026 10.80 Mn
Dec 31, 2025 9.86 Mn
Dec 31, 2025 9.86 Mn
Sep 30, 2025 13.66 Mn
Sep 30, 2025 13.66 Mn
Jun 30, 2025 3.70 Mn
Jun 30, 2025 3.70 Mn
Mar 31, 2025 1.10 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 2.72 Mn
Dec 31, 2024 2.72 Mn
Sep 30, 2024 4.89 Mn
Sep 30, 2024 4.89 Mn
Jun 30, 2024 3.19 Mn
Jun 30, 2024 3.19 Mn
Mar 31, 2024 899,264.00
Mar 31, 2024 899,264.00
Dec 31, 2023 2.33 Mn
Dec 31, 2023 2.33 Mn